As a PBM focused on workers’ compensation, myMatrixx is dedicated to highly proactive customer support and a full suite of data-driven pharmacy, clinical and regulatory solutions to mitigate risk and safely guide injured workers on their path to recovery.
Advanced automation and decision intelligence tools have tremendous potential to streamline workflows and improve efficiency for claims professionals, eliminating pain points and freeing up the workforce to focus on patient engagement and better outcomes. Learn more from Mike Cirillo, President of myMatrixx, along with Paul King, Chief Client Officer and Cliff Belliveau, Chief Innovation Officer.
The annual Drug Trend Report is released as a comprehensive analysis of the major drivers in the sector of WC retail pharmacy. Delivering the report in 2021 has required us to examine the truly unprecedented circumstances of the last 12 months, and undoubtedly, 2020 was a historic year.
This report shares the statistics and factors behind the growing trend of retirement age employees, as well as the recommendations for preventing and managing work-related injuries among older workers.
Specialty medicines are rapidly approaching half of total drug spend. Across all settings, specialty medicines treat relatively few patients and have costs far higher per patient than traditional medicines.
To highlight the benefits of recently launched program, myMatrixx myRXAdvocateSM, and to provide a deeper understanding of the principle of pharmacovigilance that it’s built on, our Chief Clinical Officer Phil Walls recently sat down to record video blog series.